Perceval S Aortic Heart Valve Study- North America
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 355 participants.
Also called NCT01810679
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 355 participants
- Sponsor
- Sorin Group USA, Inc.
- Registry
-
NCT01810679
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01810679. Allocation not applicable; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2016-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Perceval S Aortic Heart Valve Study- North America
- Condition
- Aortic Valve Stenosis
- Condition
- Aortic Valve Stenosis With Insufficiency
- Condition
- Regurgitation, Aortic Valve
- Condition
- Aortic Valve Incompetence
- Intervention (Device)
- Perceval S Aortic Heart Valve
- Lead sponsor
- Sorin Group USA, Inc.
Record details
- Record id
cardio:ct-nct01810679- Content hash
7955ab155da7ff66b78062bfcae02bebf5a7746015e97b00d8d5a10ce031ed8f